TipRanks on MSN1 天
GSK downgraded to Hold from Buy at Jefferies
Jefferies analyst Peter Welford downgraded GSK (GSK) to Hold from Buy with a price target of $39.50, down from $53. The firm ...
Meet the Finalists: American Lawyer Litigator of the Year
The winner will be announced Wednesday evening at The American Lawyer's Industry Awards. These attorneys have been named ...